Sotera Health (NASDAQ:SHC) Releases FY 2026 Earnings Guidance

Sotera Health (NASDAQ:SHC) updated its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 0.950-1.010 for the period, compared to the consensus earnings per share estimate of 0.950. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on SHC. Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. UBS Group set a $19.00 target price on Sotera Health in a research note on Wednesday, June 24th. The Goldman Sachs Group started coverage on shares of Sotera Health in a report on Friday, June 5th. They issued a “buy” rating and a $20.00 price target on the stock. Weiss Ratings upgraded shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Finally, Piper Sandler restated an “overweight” rating and set a $22.00 price target (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $20.25.

Sotera Health Trading Down 0.7%

NASDAQ:SHC opened at $17.98 on Thursday. Sotera Health has a 12 month low of $11.00 and a 12 month high of $19.85. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. The firm’s 50 day moving average is $17.00 and its 200 day moving average is $16.32. The stock has a market capitalization of $5.13 billion, a PE ratio of 43.85 and a beta of 1.77.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business had revenue of $280.05 million during the quarter, compared to analyst estimates of $270.78 million. During the same period in the prior year, the company earned $0.14 earnings per share. Sotera Health’s revenue was up 10.0% compared to the same quarter last year. Sell-side analysts expect that Sotera Health will post 0.87 earnings per share for the current year.

Insider Activity

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 15.36% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Sotera Health

Several large investors have recently added to or reduced their stakes in SHC. Sculptor Capital LP lifted its holdings in Sotera Health by 27.2% during the second quarter. Sculptor Capital LP now owns 11,500,000 shares of the company’s stock valued at $127,880,000 after purchasing an additional 2,462,489 shares during the last quarter. Janus Henderson Group PLC increased its stake in shares of Sotera Health by 4.8% in the fourth quarter. Janus Henderson Group PLC now owns 6,772,059 shares of the company’s stock worth $119,460,000 after purchasing an additional 312,191 shares in the last quarter. State Street Corp increased its stake in shares of Sotera Health by 21.0% in the fourth quarter. State Street Corp now owns 5,965,326 shares of the company’s stock worth $105,228,000 after purchasing an additional 1,035,457 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Sotera Health by 11.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 5,160,594 shares of the company’s stock valued at $91,036,000 after purchasing an additional 524,012 shares during the period. Finally, AQR Capital Management LLC lifted its stake in shares of Sotera Health by 1,206.2% during the 4th quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock valued at $50,523,000 after buying an additional 2,644,831 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.